1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with lipoteichoic acid in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (lipoteichoic acid) | Trials (lipoteichoic acid) | Recent Studies (post-2010) (lipoteichoic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,625 | 12 | 646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burroughs, M; Cabellos, C; Forrest, M; MacIntyre, DE; Prasad, S; Tuomanen, E | 1 |
| De Kimpe, SJ; Thiemermann, C; Vane, JR | 1 |
| Albert, DH; Carter, GW; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Summers, JB; Tapang, P | 1 |
| Al-Hassani, M; Billings, SD; Howard, KM; Ishii, S; Mousdicas, N; Perkins, SM; Shimizu, T; Travers, JB; Yi, Q; Zhang, Q | 1 |
| Draing, C; Golenbock, DT; Haslinger, I; Knapp, S; Leendertse, M; van der Poll, T; von Aulock, S | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lipoteichoic acid
| Article | Year |
|---|---|
Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.
Topics: Animals; Brain; Cell Degranulation; Inflammation; Lipopolysaccharides; Lung; Meningitis, Pneumococcal; Neutralization Tests; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pneumonia, Pneumococcal; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Streptococcus pneumoniae; Subarachnoid Space; Teichoic Acids | 1992 |
Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
Topics: Acute Kidney Injury; Animals; Azepines; Cells, Cultured; Diterpenes; Ginkgolides; Hemodynamics; Lactones; Lipopolysaccharides; Lung; Male; Nitric Oxide Synthase; Nitrites; Norepinephrine; Plant Extracts; Platelet Activating Factor; Rats; Rats, Wistar; Shock, Septic; Streptomyces; Teichoic Acids; Triazoles; Tumor Necrosis Factor-alpha | 1995 |
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
Topics: Animals; Consciousness; Disseminated Intravascular Coagulation; Endotoxemia; Endotoxins; Gastrointestinal Hemorrhage; Hypotension; Lipopolysaccharides; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Teichoic Acids; Thiazoles | 1996 |
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
Topics: Animals; Calcium; Cell Line; Dermatitis, Atopic; Dinitrofluorobenzene; Drug Hypersensitivity; Drug Synergism; Humans; Hypersensitivity, Delayed; Inflammation; Interleukin-10; Lipopolysaccharides; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids; Th1 Cells; Th2 Cells | 2005 |
Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor.
Topics: Acute Disease; Animals; Cell Line; Female; Humans; Inflammation Mediators; Lipopolysaccharide Receptors; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumonia, Bacterial; Pulmonary Alveoli; Receptors, G-Protein-Coupled; Teichoic Acids; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2008 |